DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2201156/merck-s-mrk-chronic-cough-drug-gets-another-crl-from-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201156 Dec 21, 2023 - Per the FDA, the data submitted by Merck (MRK) for its chronic cough drug did not provide sufficient evidence to prove its clinical benefit in patients. 0

https://www.zacks.com/stock/news/2202750/why-you-should-invest-in-encompass-health-ehc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202750 Dec 27, 2023 - Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves. 0

https://www.zacks.com/commentary/2202579/top-analyst-reports-for-novo-nordisk-walmart-amd?cid=CS-ZC-FT-research_daily-2202579 Dec 27, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Walmart Inc. (WMT) and Advanced Micro Devices, Inc. (AMD). 0

https://www.zacks.com/stock/news/2204853/here-s-why-you-should-invest-in-aquestive-aqst-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204853 Jan 03, 2024 - Here, we discuss some reasons why buying Aquestive Therapeutics (AQST) stock now may turn out to be a prudent move. 0

https://www.zacks.com/stock/news/2205299/novo-nordisk-nvo-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2205299 Jan 03, 2024 - In the closing of the recent trading day, Novo Nordisk (NVO) stood at $103.62, denoting a +1.48% change from the preceding trading day. 0

https://www.zacks.com/stock/news/2205527/here-s-why-you-should-invest-in-adverum-advm-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205527 Jan 04, 2024 - Here, we discuss some reasons why buying Adverum Biotechnologies (AQST) stock now may turn out to be a prudent move. 0

https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases. 0

https://www.zacks.com/stock/news/2208771/want-better-returns-don-t-ignore-these-2-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2208771 Jan 11, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. 0

https://www.zacks.com/stock/news/2209718/emergent-ebs-gets-235-8m-dod-contract-for-anthrax-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209718 Jan 12, 2024 - Emergent (EBS) signs a deal with the U.S. Department of Defense to supply its anthrax vaccine initially for a five-year period, with an option to extend it for another five years. 0

https://www.zacks.com/stock/news/2209723/unitedhealth-group-unh-q4-earnings-beat-on-membership-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-2209723 Jan 12, 2024 - UnitedHealth Group's (UNH) Q4 results benefit on the back of double-digit revenue growth in its UnitedHealthcare and Optum segments. Management maintains its 2024 adjusted EPS target within $27.50-$28.00. 0